Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 May;79(5):1325–1329. doi: 10.1172/JCI112957

Developmental changes in the rat atriopeptin hormonal system.

Y F Wei, C P Rodi, M L Day, R C Wiegand, L D Needleman, B R Cole, P Needleman
PMCID: PMC424376  PMID: 2952670

Abstract

We undertook a study of fetal synthesis, storage, and release of atriopeptin (AP). Plasma levels of both atriopeptin immunoreactivity (APir) and the NH2-terminal fragment of the prohormone immunoreactivity (NTFir) were very high in the fetus (4 and 20 times the maternal plasma, respectively). However, the atrial content of the AP was low, but surprisingly, ventricular content of AP was quite high (relative to the adult) in the fetus and fell postnatally. Atrial AP messenger RNA (mRNA) increased with postnatal age, whereas ventricular mRNA was extremely high in the fetus and fell rapidly after birth. High fetal plasma peptide levels may derive from the mother since infusion of exogenous atriopeptin 24 into the mother resulted in parallel increases in fetal and maternal peptide levels. Fetal plasma APir and NTFir levels partially reflect the markedly reduced total renal metabolic capacity compared with that of the adult. Plasma levels fell progressively after birth; whereas neonatal atrial content rose substantially. Plasma AP and NTF were simultaneously elevated in both the maternal and fetal circulation after vasopressin injection of the mother. The fetus can also respond to exogenous stimuli (vasopressin or indomethacin--presumably via ductal closure) and promptly release substantial amounts of peptide into its circulation. Thus, it appears that the AP hormonal system is functional during fetal life and responds avidly to increases in intracardiac pressure as does the mature animal.

Full text

PDF
1325

Images in this article

1327Image
on p.1327
1327Image
on p.1327
1327Image
on p.1327
1327Image
on p.1327
1327Image
on p.1327
1327Image
on p.1327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballerman B. J., Brenner B. M. Biologically active atrial peptides. J Clin Invest. 1985 Dec;76(6):2041–2048. doi: 10.1172/JCI112206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clyman R. I., Mauray F., Heymann M. A., Rudolph A. M. Ductus arteriosus: developmental response to oxygen and indomethacin. Prostaglandins. 1978 Jun;15(6):993–998. doi: 10.1016/0090-6980(78)90041-2. [DOI] [PubMed] [Google Scholar]
  3. Coceani F., Olley P. M. Role of prostaglandins, prostacyclin, and thromboxanes in the control of prenatal patency and postnatal closure of the ductus arteriosus. Semin Perinatol. 1980 Apr;4(2):109–113. [PubMed] [Google Scholar]
  4. Cogan E., Debiève M. F., Philipart I., Pepersack T., Abramow M. High plasma levels of atrial natriuretic factor in SIADH. N Engl J Med. 1986 May 8;314(19):1258–1259. doi: 10.1056/NEJM198605083141921. [DOI] [PubMed] [Google Scholar]
  5. Imada T., Takayanagi R., Inagami T. Changes in the content of atrial natriuretic factor with the progression of hypertension in spontaneously hypertensive rats. Biochem Biophys Res Commun. 1985 Dec 17;133(2):759–765. doi: 10.1016/0006-291x(85)90969-6. [DOI] [PubMed] [Google Scholar]
  6. Kagan B. M., Stanincova V., Felix N. S., Hodgman J., Kalman D. Body composition of premature infants: relation to nutrition. Am J Clin Nutr. 1972 Nov;25(11):1153–1164. doi: 10.1093/ajcn/25.11.1153. [DOI] [PubMed] [Google Scholar]
  7. Maack T., Camargo M. J., Kleinert H. D., Laragh J. H., Atlas S. A. Atrial natriuretic factor: structure and functional properties. Kidney Int. 1985 Apr;27(4):607–615. doi: 10.1038/ki.1985.54. [DOI] [PubMed] [Google Scholar]
  8. Manning P. T., Schwartz D., Katsube N. C., Holmberg S. W., Needleman P. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science. 1985 Jul 26;229(4711):395–397. doi: 10.1126/science.2990050. [DOI] [PubMed] [Google Scholar]
  9. McKenzie J. C., Tanaka I., Inagami T., Misono K. S., Klein R. M. Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. Proc Soc Exp Biol Med. 1986 Mar;181(3):459–463. doi: 10.3181/00379727-181-rc3. [DOI] [PubMed] [Google Scholar]
  10. Michener M. L., Gierse J. K., Seetharam R., Fok K. F., Olins P. O., Mai M. S., Needleman P. Proteolytic processing of atriopeptin prohormone. Mol Pharmacol. 1986 Dec;30(6):552–557. [PubMed] [Google Scholar]
  11. Needleman P., Adams S. P., Cole B. R., Currie M. G., Geller D. M., Michener M. L., Saper C. B., Schwartz D., Standaert D. G. Atriopeptins as cardiac hormones. Hypertension. 1985 Jul-Aug;7(4):469–482. doi: 10.1161/01.hyp.7.4.469. [DOI] [PubMed] [Google Scholar]
  12. Needleman P., Greenwald J. E. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med. 1986 Mar 27;314(13):828–834. doi: 10.1056/NEJM198603273141306. [DOI] [PubMed] [Google Scholar]
  13. Oh W., Stewart L., Baens G. S., Metcoff J. Body composition and renal adaptation in the newborn rat. Biol Neonat. 1965;8(2):65–80. doi: 10.1159/000239947. [DOI] [PubMed] [Google Scholar]
  14. Sagnella G. A., Markandu N. D., Shore A. C., MacGregor G. A. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet. 1986 Jan 25;1(8474):179–181. doi: 10.1016/s0140-6736(86)90653-7. [DOI] [PubMed] [Google Scholar]
  15. Schiffrin E. L., Gutkowska J., Kuchel O., Cantin M., Genest J. Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. N Engl J Med. 1985 May 2;312(18):1196–1197. doi: 10.1056/NEJM198505023121822. [DOI] [PubMed] [Google Scholar]
  16. Schwartz D., Geller D. M., Manning P. T., Siegel N. R., Fok K. F., Smith C. E., Needleman P. Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science. 1985 Jul 26;229(4711):397–400. doi: 10.1126/science.3160114. [DOI] [PubMed] [Google Scholar]
  17. Sen I. Identification and solubilization of atrial natriuretic factor receptors in human placenta. Biochem Biophys Res Commun. 1986 Mar 13;135(2):480–486. doi: 10.1016/0006-291x(86)90019-7. [DOI] [PubMed] [Google Scholar]
  18. Yamaji T., Ishibashi M., Nakaoka H., Imataka K., Amano M., Fujii J. Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias. Lancet. 1985 May 25;1(8439):1211–1211. doi: 10.1016/s0140-6736(85)92883-1. [DOI] [PubMed] [Google Scholar]
  19. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES